Terms: = Breast cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2
96160 results:
1. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T; Cottone F; Dunton K; André F; Krop I; Park YH; De Laurentiis M; Miyoshi Y; Armstrong A; Borrego MR; Yerushalmi R; Duhoux FP; Takano T; Lu W; Egorov A; Kim SB
Lancet Oncol; 2024 May; 25(5):614-625. PubMed ID: 38697155
[TBL] [Abstract] [Full Text] [Related]
2. A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple-negative breast cancer.
Lin WD; Chang CH; Pan JK; Lin FC; Chen YC; Chen YJ; Wang PS; Hong WQ; Chen SY; Lin CH; Kuo YL; Chung WP; Cheng HC; Hsiao M; Yang CN; Lu PJ
Cell Death Dis; 2024 May; 15(5):310. PubMed ID: 38697967
[TBL] [Abstract] [Full Text] [Related]
3. Targeted photodynamic therapy technique of Janus nanoparticles on breast cancer.
Montaseri H; Abrahamse H
Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):270-277. PubMed ID: 38696132
[TBL] [Abstract] [Full Text] [Related]
4. Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women.
Nykänen A; Sudah M; Masarwah A; Vanninen R; Okuma H
Sci Rep; 2024 May; 14(1):10001. PubMed ID: 38693256
[TBL] [Abstract] [Full Text] [Related]
5. Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With breast cancer.
Shaw JA; Page K; Wren E; de Bruin EC; Kalashnikova E; Hastings R; McEwen R; Zhang E; Wadsley M; Acheampong E; Renner D; Gleason KLT; Ambasager B; Stetson D; Fernandez-Garcia D; Guttery D; Allsopp RC; Rodriguez A; Zimmermann B; Sethi H; Aleshin A; Liu MC; Richards C; Stebbing J; Ali S; Rehman F; Cleator S; Kenny L; Ahmed S; Armstrong AC; Coombes RC
JCO Precis Oncol; 2024 Apr; 8():e2300456. PubMed ID: 38691816
[TBL] [Abstract] [Full Text] [Related]
6. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract] [Full Text] [Related]
7. Diffusion probabilistic versus generative adversarial models to reduce contrast agent dose in breast MRI.
Müller-Franzes G; Huck L; Bode M; Nebelung S; Kuhl C; Truhn D; Lemainque T
Eur Radiol Exp; 2024 May; 8(1):53. PubMed ID: 38689178
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating Recurrence Risk in Patients Undergoing breast-conserving Surgery Using E-cadherin Staining as a Biomarker.
Kao CN; Chen CC; Chu WL; Luo CW; Huang WL; Moi SH; Hou MF; Pan MR
In Vivo; 2024; 38(3):1143-1151. PubMed ID: 38688621
[TBL] [Abstract] [Full Text] [Related]
9. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
10. Addition of Contrast-enhanced Mammography to Tomosynthesis for breast cancer Detection in Women with a Personal History of breast cancer: Prospective TOCEM Trial Interim Analysis.
Berg WA; Berg JM; Bandos AI; Vargo A; Chough DM; Lu AH; Ganott MA; Kelly AE; Nair BE; Hartman JY; Waheed U; Hakim CM; Harnist KS; Reginella RF; Shinde DD; Carlin BA; Cohen CS; Wallace LP; Sumkin JH; Zuley ML
Radiology; 2024 Apr; 311(1):e231991. PubMed ID: 38687218
[TBL] [Abstract] [Full Text] [Related]
11. BI-RADS Category Assignments by GPT-3.5, GPT-4, and Google Bard: A Multilanguage Study.
Cozzi A; Pinker K; Hidber A; Zhang T; Bonomo L; Lo Gullo R; Christianson B; Curti M; Rizzo S; Del Grande F; Mann RM; Schiaffino S
Radiology; 2024 Apr; 311(1):e232133. PubMed ID: 38687216
[TBL] [Abstract] [Full Text] [Related]
12. Doxorubicin, doxorubicinol, cardiotoxicity, breast cancer, volumetric absorptive microsampling, LC-MS/MS.
Chairunnisa DF; Harahap Y; Juanita M; Syafhan NF; Purwanto DJ
Pak J Biol Sci; 2024 Mar; 27(3):125-131. PubMed ID: 38686734
[TBL] [Abstract] [Full Text] [Related]
13. [Malignant Adenomyoepithelioma of the breast:Report of One Case and Literature Review].
Zhao Y; Wen WJ; Zhang XD; An FX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):301-306. PubMed ID: 38686730
[TBL] [Abstract] [Full Text] [Related]
14. Identifying priority areas to support primary care engagement in breast cancer survivorship care: A Delphi study.
Mikesell L; O'Malley DM; Kurtzman RT; Howard J; Bates B; Hemler JR; Fadem SJ; Ferrante JM; Bator A; Hudson SV; Crabtree BF
Cancer Med; 2024 May; 13(9):e7219. PubMed ID: 38686635
[TBL] [Abstract] [Full Text] [Related]
15. breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer.
Smith RE; Sprague BL; Henderson LM; Kerlikowske K; Miglioretti DL; Wernli KJ; Onega T; diFlorio-Alexander RM; Tosteson ANA
Breast Cancer Res; 2024 Apr; 26(1):73. PubMed ID: 38685119
[TBL] [Abstract] [Full Text] [Related]
16. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
17. Cytotoxic and apoptotic effects of Ferula gummosa Boiss: extract on human breast adenocarcinoma cell line.
Rashidi R; Roohbakhsh A; Mohtashami L; Mobasheri L; Kheradmand H; Amiri MS; Ghorbani A; Mousavi SH
Mol Biol Rep; 2024 Apr; 51(1):592. PubMed ID: 38683376
[TBL] [Abstract] [Full Text] [Related]
18. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
19. Hopelessness and Social Support among cancer Patients in Saudi Arabia.
Rawas H; De Beer J; Alturki O; Altorki M; Alhelali T; Althagfi A; Faisal N; Albalawi F; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1363-1370. PubMed ID: 38679998
[TBL] [Abstract] [Full Text] [Related]
20. Investigations of Ni(II)Cysteine-Tyrosine Dithiocarbamate Complex: Synthesis, Characterization, Molecular Docking, Molecular Dynamic, and Anticancer Activity on MCF-7 breast cancer Cell Line.
Pratiwi E; Raya I; Natsir H; Irfandi R; Taba P; Arfah R; Rasyid H; Hala Y; Kasim S; Khaerunnisa AB; Ilham B; Mazaya M; Tanzil Y; Luthfiana D
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1301-1313. PubMed ID: 38679991
[TBL] [Abstract] [Full Text] [Related]
[Next]